159 related articles for article (PubMed ID: 16528971)
1. Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system.
Wakabayashi K; Nakagawa H; Adachi T; Kii I; Kobatake E; Kudo A; Ishikawa T
J Exp Ther Oncol; 2006; 5(3):205-22. PubMed ID: 16528971
[TBL] [Abstract][Full Text] [Related]
2. Effect of cysteine mutagenesis on the function and disulfide bond formation of human ABCG2.
Liu Y; Yang Y; Qi J; Peng H; Zhang JT
J Pharmacol Exp Ther; 2008 Jul; 326(1):33-40. PubMed ID: 18430864
[TBL] [Abstract][Full Text] [Related]
3. Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein.
Wakabayashi K; Nakagawa H; Tamura A; Koshiba S; Hoshijima K; Komada M; Ishikawa T
J Biol Chem; 2007 Sep; 282(38):27841-6. PubMed ID: 17686774
[TBL] [Abstract][Full Text] [Related]
4. A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.
Mitomo H; Kato R; Ito A; Kasamatsu S; Ikegami Y; Kii I; Kudo A; Kobatake E; Sumino Y; Ishikawa T
Biochem J; 2003 Aug; 373(Pt 3):767-74. PubMed ID: 12741957
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system.
Tamura A; Wakabayashi K; Onishi Y; Nakagawa H; Tsuji M; Matsuda Y; Ishikawa T
J Exp Ther Oncol; 2006; 6(1):1-11. PubMed ID: 17228519
[TBL] [Abstract][Full Text] [Related]
6. Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.
Hou YX; Li CZ; Palaniyandi K; Magtibay PM; Homolya L; Sarkadi B; Chang XB
Biochemistry; 2009 Sep; 48(38):9122-31. PubMed ID: 19691360
[TBL] [Abstract][Full Text] [Related]
7. N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.
Diop NK; Hrycyna CA
Biochemistry; 2005 Apr; 44(14):5420-9. PubMed ID: 15807535
[TBL] [Abstract][Full Text] [Related]
8. Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.
Henriksen U; Fog JU; Litman T; Gether U
J Biol Chem; 2005 Nov; 280(44):36926-34. PubMed ID: 16107343
[TBL] [Abstract][Full Text] [Related]
9. Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2.
Nakagawa H; Wakabayashi-Nakao K; Tamura A; Toyoda Y; Koshiba S; Ishikawa T
FEBS J; 2009 Dec; 276(24):7237-52. PubMed ID: 19909340
[TBL] [Abstract][Full Text] [Related]
10. Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers.
Bhatia A; Schäfer HJ; Hrycyna CA
Biochemistry; 2005 Aug; 44(32):10893-904. PubMed ID: 16086592
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity.
Xu J; Peng H; Chen Q; Liu Y; Dong Z; Zhang JT
Cancer Res; 2007 May; 67(9):4373-81. PubMed ID: 17483351
[TBL] [Abstract][Full Text] [Related]
12. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
Henriksen U; Gether U; Litman T
J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
[TBL] [Abstract][Full Text] [Related]
13. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2.
Nakagawa H; Tamura A; Wakabayashi K; Hoshijima K; Komada M; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
Biochem J; 2008 May; 411(3):623-31. PubMed ID: 18237272
[TBL] [Abstract][Full Text] [Related]
15. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.
Tamura A; Watanabe M; Saito H; Nakagawa H; Kamachi T; Okura I; Ishikawa T
Mol Pharmacol; 2006 Jul; 70(1):287-96. PubMed ID: 16608919
[TBL] [Abstract][Full Text] [Related]
16. A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions.
Saito H; Hirano H; Nakagawa H; Fukami T; Oosumi K; Murakami K; Kimura H; Kouchi T; Konomi M; Tao E; Tsujikawa N; Tarui S; Nagakura M; Osumi M; Ishikawa T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1114-24. PubMed ID: 16489126
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
[TBL] [Abstract][Full Text] [Related]
18. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2.
Xu J; Liu Y; Yang Y; Bates S; Zhang JT
J Biol Chem; 2004 May; 279(19):19781-9. PubMed ID: 15001581
[TBL] [Abstract][Full Text] [Related]
19. Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.
Furukawa T; Wakabayashi K; Tamura A; Nakagawa H; Morishima Y; Osawa Y; Ishikawa T
Pharm Res; 2009 Feb; 26(2):469-79. PubMed ID: 18958403
[TBL] [Abstract][Full Text] [Related]
20. Production of cells with targeted integration of gene variants of human ABC transporter for stable and regulated expression using the Flp recombinase system.
Wakabayashi-Nakao K; Tamura A; Koshiba S; Toyoda Y; Nakagawa H; Ishikawa T
Methods Mol Biol; 2010; 648():139-59. PubMed ID: 20700710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
